FDA Adverse Event Malfunction Summary report: N

CAPTURE-R READY SCREEN I AND II

MDR report key: 2309228 · Received October 26, 2011

Report

Report Number
1034569-2011-00168
Event Type
Malfunction
Date Received
October 26, 2011
Date of Event
September 27, 2011
Report Date
October 26, 2011
Manufacturer
IMMUCOR, INC.
Product Code
KSZ
PMA / PMN Number
STN 102707
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
MEDICAL TECHNOLOGIST

Narratives

Additional Manufacturer Narrative · 1

A REVIEW OF THE IMAGES SHOW THAT WELL B07 LOOKED EQUIVOCAL. WELL A07 LOOKED NEGATIVE. CELL 2 SHOULD HAVE BEEN POSITIVE. WELLS C02 AND D02 ARE BOTH STRONG POSITIVES. THE CUSTOMER RETESTED THE SAMPLE USING A NEW LOT OF PLATES AND THE SAME LOT OF INDICATOR CELLS. THE SAMPLE WAS POSITIVE WITH 2_CELL PLATES LOT X350. SWITCHING TO A NEW LOT OF PLATES RESOLVED THE ISSUE. CONFIRMED THE REACTIVITY OF THE K ANTIGEN ON RETENTIONS CAPTURE-R READY-SCREEN (2) (CRRS2), LOT X349 USING MANUAL CAPTURE WITH RETENTIONS CAPTURE-R READY INDICATOR RED CELLS (CRRIRC), LOT 221720, AND ANTI-K, LOT QC#1 (1:250 DILUTION). CONTROLS PERFORMED AS EXPECTED AND ALL REAGENT RED CELLS TESTED EXHIBITED THE EXPECTED REACTIVITY. CONFIRMED THE REACTIVITY OF THE K ANTIGEN ON RETURN CAPTURE-R READY-SCREEN (2) (CRRS2), LOT X349 USING MANUAL CAPTURE WITH RETENTIONS CAPTURE-R READY INDICATOR RED CELLS (CRRIRC), LOT 221720, AND ANTI-K, LOT QC#1 (1:250 DILUTION). CONTROLS PERFORMED AS EXPECTED AND ALL REAGENT RED CELLS TESTED EXHIBITED THE EXPECTED REACTIVITY. THIS INVESTIGATION DID NOT IDENTIFY A PRODUCT DEFICIENCY. THE CUSTOMER ISSUE WAS NOT REPRODUCED OR CONFIRMED.

Description of Event or Problem · 1

A CUSTOMER REPORTED UNEXPECTED NEGATIVE REACTIONS WHEN TESTING A PATIENT SAMPLE WITH CAPTURE-R READY SCREEN (CRRS) I AND II ON THE GALILEO INSTRUMENT. THE PATIENT HAS A KNOWN ANTI-KELL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 CAPTURE-R READY SCREEN I AND II REAGENT RED BLOOD CELL KSZ IMMUCOR, INC. X349

Patients

Seq Age Sex Outcome Treatment
1 84 YR